Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia (PPFP Choices)

August 16, 2021 updated by: Jhpiego

The primary goal of PPFP Choices is to generate actionable evidence that can be used to increase programmatic activities to address post-pregnancy family planning in the public and private-for-profit sectors. The ultimate intent of this investment is to advance and scale up post-pregnancy FP. Programmatic learning will be crucial to understanding what it will take to accelerate post-pregnancy FP in these two countries, and these can later be adapted by other countries with similar settings. Our vision of PPFP Choices can be achieved through the following objectives:

  • Objective 1: Establish a comprehensive program implementation framework for the private sector to embrace post-pregnancy FP
  • Objective 2: Improve the quality of post-pregnancy FP counseling and service provision in both public and private sectors
  • Objective 3: Build evidence and contribute to the literature and programmatic guidance around post-pregnancy FP uptake and continuation in both public and private sectors
  • Objective 4: Ensure effective documentation and strategic dissemination which will benefit post-pregnancy FP introduction and scale-up more broadly

Study Overview

Detailed Description

PPFP Choices is an operations research study seeking to examine the barriers and facilitators in offering a full range of FP methods in the immediate post-pregnancy period in both the public and private sectors.

Jhpiego will implement the study in two counties in Kenya; Meru and Kilifi, and two districts in Indonesia; Brebes and Batang.

This study will employ a quasi-experimental design with an intervention and control group. Prior to study start-up, the the intervention group will receive a Jhpiego-designed package of interventions designed to advance post-pregnancy FP in both the public and private sectors. These interventions draw on WHO's Programming Strategies for Postpartum Family Planning, as well as Jhpiego's experience and assessments. After the study is completed, the control groups will receive the same intervention. For the study, a mixed method approach will be used; both quantitative and qualitative data will be collected through Client Quantitative Interviews, Client In-Depth interviews, Focus Group Discussions, Key Informant Interviews, and Facility Assessments.

Study Type

Interventional

Enrollment (Actual)

9282

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central Java
      • Batang, Central Java, Indonesia, 51216
        • RSU QOlbu Insan Mulia
      • Batang, Central Java, Indonesia, 51262
        • Puskesmas Subah
    • Jawa Tengah
      • Batang, Jawa Tengah, Indonesia, 51215
        • RSUD Batang
      • Batang, Jawa Tengah, Indonesia, 51274
        • Puskesmas Bawang
      • Brebes, Jawa Tengah, Indonesia, 52212
        • RSUD Brebes
      • Brebes, Jawa Tengah, Indonesia, 52255
        • Puskesmas Kecipir
      • Brebes, Jawa Tengah, Indonesia, 52263
        • Puskesmas Ketanggungan
      • Brebes, Jawa Tengah, Indonesia, 52273
        • RSU Alam Medika Bumi Ayu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 49 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Kenyan postpartum participant (Enrollment starts at ANC):

    1. At least 28 weeks pregnant
    2. Plans to deliver at the study facility
    3. Aged 15-49 years at enrollment
    4. Provides voluntary informed consent
    5. Not planning to relocate in the next 12 months
  2. Indonesian postpartum participant (Enrollment starts at L&D):

    1. In the immediate postpartum period (within 72 hours, prior to leaving the health facility),
    2. Reported having attended ANC within her 3rd trimester (28-weeks pregnant and later),
    3. Aged 15-49 years at time of enrollment (Indonesian adolescents aged 15-16 must be married for purposes of the study consent)
    4. Provides voluntary informed consent
    5. Not planning to relocate in the next 12 months
  3. Kenyan and Indonesian postabortion participants:

    1. A female in the immediate post-pregnancy treatment phase (within 72 hours in Indonesia, within 48 hours in Kenya, prior to leaving the health facility for treatment of incomplete abortion)
    2. Aged 15-49 years at time of enrollment (Indonesian adolescents aged 15-16 must be married for purposes of the study consent)
    3. Provides voluntary informed consent
    4. Not planning to relocate in the next 6 months

Exclusion Criteria:

  1. Refusal to sign consent form for inclusion in the study
  2. Post-delivery baby or mother being treated for trauma or in an intensive care unit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention will be applied to health facilities in one district in Indonesia and one county in Kenya. The intervention package will work within existing public and private health facilities to strengthen and assess the effectiveness of facility and provider level PPFP service provision and counseling, and expand method choice for women during antenatal, early labor, and post-pregnancy pre-discharge periods. Training within the intervention package include provider-lever PPFP counseling and service provision (PPFP Clinical and Counseling Skills), as well as provider and facility-level leadership management and governance training (Facility-Level Leadership Management and Governance Training).
Facilities will receive whole-site orientations on PPFP basics and skills Through training of trainers, followed by classroom and model-based and clinical-based practice, providers will receive training in PPDP counseling and service provision.
The intervention will strengthen leadership management and governance practices required to help managers establish PPFP services at the facility level.
No Intervention: Control
The health facilities control district in Indonesia and county in Kenya will continue with their standard counseling and service provision throughout the study period. At the conclusion of the study period, the facilities in these areas will receive the same intervention that Intervention facilities received prior to study startup.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of PPFP counseling
Time Frame: 3 years
80% of ANC attendees and women receiving postabortion care receive appropriate PPFP counseling prior to discharge compared to baseline in the comparison group.
3 years
Clinical competency of service providers in providing all modern FP methods
Time Frame: 3 years
100% of service providers in intervention arm of study are deemed competent and retain competencies to provide all modern FP methods to women during postpartum and postabortion periods.
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum uptake of LARCs
Time Frame: 3 years
50% increase in Long-Acting and Permanent Method use by study participants whose infants are six months old in study intervention sites in Indonesia and 70% increase in LARC use by study participants whose infants are six months old in study intervention sites in Kenya. A change in use of LARCs and other permanent methods of FP by study participants whose infants are six months old, from 10% to 15% in Indonesia and from 6% to 10% in Kenya at intervention facilities over the course of the study
3 years
Health facility-level leadership management and governance skills
Time Frame: 3 years
80% of health facilities in the intervention group show improvement in leadership management and government measured through use of quality improvement approaches
3 years
Assessment of individual intervention quality
Time Frame: 3 years
Using a quality improvement framework, assess individual pieces of the intervention package using multi-level modeling
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Elaine Charurat, MBA, MHS, Jhpiego

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 9, 2017

Primary Completion (Actual)

March 16, 2020

Study Completion (Actual)

March 16, 2020

Study Registration Dates

First Submitted

October 25, 2017

First Submitted That Met QC Criteria

November 2, 2017

First Posted (Actual)

November 7, 2017

Study Record Updates

Last Update Posted (Actual)

August 17, 2021

Last Update Submitted That Met QC Criteria

August 16, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00007462

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The study protocol will be shared through publication in a peer-reviewed journal.

De-identified participant data will be submitted to a data repository in accordance with the Bill and Melinda Gates Foundation and Merck for Mothers policies.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-pregnancy Family Planning

Clinical Trials on PPFP Clinical and Counseling Skills

3
Subscribe